REMKX
Price
$18.57
Change
+$0.19 (+1.03%)
Updated
Apr 24 closing price
Net Assets
287.84M
VEIEX
Price
$28.48
Change
+$0.26 (+0.92%)
Updated
Apr 24 closing price
Net Assets
111.75B
Ad is loading...

REMKX vs VEIEX

Header iconREMKX vs VEIEX Comparison
Open Charts REMKX vs VEIEXBanner chart's image
Victory Sophus Emerging Markets R
Price$18.57
Change+$0.19 (+1.03%)
VolumeN/A
Net Assets287.84M
Vanguard Emerging Mkts Stock Idx I
Price$28.48
Change+$0.26 (+0.92%)
VolumeN/A
Net Assets111.75B
REMKX vs VEIEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
REMKX vs. VEIEX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REMKX is a Buy and VEIEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 112B vs. REMKX (288M). VEIEX pays higher dividends than REMKX: VEIEX (2.93) vs REMKX (1.88). REMKX was incepted earlier than VEIEX: REMKX (24 years) vs VEIEX (31 years). REMKX (1.99) is less costly to investors than VEIEX (0.29). REMKX is a more actively managed with annual turnover of: 72.00 vs. VEIEX (8.00). REMKX (0) and VEIEX (0) have matching initial minimum investment requirements. VEIEX annual gain was more profitable for investors over the last year : 8.73 vs. REMKX (3.92). VEIEX return over 5 years is better than : 38.91 vs. REMKX (28.41).
REMKXVEIEXREMKX / VEIEX
Total Expense Ratio1.580.29545%
Annual Report Gross Expense Ratio1.990.29686%
Fund Existence24 years31 years-
Gain YTD3.5490.748475%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets288M112B0%
Annual Yield % from dividends1.882.9364%
Returns for 1 year3.928.7345%
Returns for 3 years7.1410.8466%
Returns for 5 years28.4138.9173%
Returns for 10 years12.1817.3670%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NB2.800.21
+8.11%
NioCorp Developments Ltd
XPRO8.340.26
+3.22%
Expro Group Holdings NV
BSAC24.310.59
+2.49%
Banco Santander-Chile
FC20.740.42
+2.07%
Franklin Covey Company
PCSA0.24N/A
-0.13%
Processa Pharmaceuticals